ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
6
views
0
references
Top references
cited by
0
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
2,229
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Phase 2 study design of antisense oligonucleotide nusinersen in presymptomatic infants with spinal muscular atrophy
Author(s):
E. Bertini
,
P. Hwu
,
S. Reyna
,
W. Farwell
,
D. De
Publication date
Created:
October 2016
Publication date
(Print):
October 2016
Journal:
Neuromuscular Disorders
Publisher:
Elsevier BV
Read this article at
ScienceOpen
Publisher
Review
Review article
Invite someone to review
Bookmark
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
NTT Journal for Theology and the Study of Religion
Author and article information
Journal
Title:
Neuromuscular Disorders
Abbreviated Title:
Neuromuscular Disorders
Publisher:
Elsevier BV
ISSN (Print):
09608966
Publication date Created:
October 2016
Publication date (Print):
October 2016
Volume
: 26
Page
: S210
Article
DOI:
10.1016/j.nmd.2016.06.450
SO-VID:
7bf79967-bc8d-4f92-b6ad-02423a228506
Copyright ©
© 2016
License:
https://www.elsevier.com/tdm/userlicense/1.0/
History
Data availability:
Comments
Comment on this article
Sign in to comment
scite_
Similar content
2,229
Spinal muscular atrophy: an integrated medical and pharmacy claims analysis of nusinersen uptake and gene therapy forecast among 15 million commercially insured
Authors:
C Starner
,
P Gleason
Nusinersen improves motor function in infants with and without permanent ventilation: results from the ENDEAR study in infantile-onset spinal muscular atrophy (SMA)
Authors:
E. McNeil
,
R Finkel
,
B Darras
Nusinersen in infants who initiate treatment in a presymptomatic stage of SMA: Interim efficacy and safety results from the phase 2 NURTURE study
Authors:
KJ Swoboda
,
DC De Vivo
,
E Bertini
…
See all similar